[Rare solid pancreatic tumors].
The most common tumor of the pancreas is cancer, which constitutes 85% of all pancreatic neoplasms. Cystic pancreatic tumors comprise 10% of malignancies. No more than 5% of pancreatic tumors are rare solid tumors as: neuroendocrine tumors, gastrointestinal stromal tumors, solid pseudopapillary tumors, pecomas, lymphomas, granulocytic sarcomas, schwannomas, lipomas, liposarcomas and metastases to pancreas. Nowadays, these tumors are diagnosed more commonly due to the developement and accessibility of the diagnostic imaging techniques. Moreover, the treatment and management of rare solid pancreatic tumors often differs from the management in pancreatic cancer what makes the differential diagnosis difficult and responsible challenge. The main purpose of this article is to present an actual data of epidemiology, clinical presentation, management and treatment of rare solid pancreatic tumors according to recent literature and self experience.
Pomorski Uniwersytet Medyczny w Szczecinie, Katedra i Klinika Gastroenterologii. kgastro@sci.pam.szczecin.pl
Krzysztof
K
Dabkowski
Klaudyna
K
Kojder
Andrzej
A
Smereczyński
Jerzy
J
Lubikowski
Marek
M
Patalan
Teresa
T
Starzyńska
D003937:Diagnosis, Differential; D006801:Humans; D008067:Lipoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D008080:Liposarcoma / Q000175:diagnosis / Q000473:pathology / Q000556:secondary / Q000628:therapy; D008223:Lymphoma / Q000175:diagnosis / Q000473:pathology / Q000628:therapy; D009442:Neurilemmoma / Q000175:diagnosis / Q000473:pathology / Q000556:secondary / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000556:secondary / Q000628:therapy*; D035583:Rare Diseases; D012509:Sarcoma / Q000175:diagnosis / Q000473:pathology / Q000556:secondary / Q000628:therapy